Vascular leak in a rat model of preeclampsia

American Journal of Nephrology

Volumn 30, Issue 1, 2009, Pages 26-33

  Uddin, Mohammad N ^a   McLean, Luciana B ^a   Hunter, Felicia A ^b   Horvat, Darijana ^a   Severson, Judson ^a   Tharakan, Binu ^b   Childs, Ed W ^b   Puschett, Jules B ^a  

^a Division of Nephrology and Hypertension   (United States)

^b Texas AandM University of the Health Sciences Center   (United States)

Author keywords

Capillary leak; Marinobufagenin; Preeclampsia; Vascular permeability

Indexed keywords

ALBUMIN; CASPASE 3; CASPASE 8; CYTOCHROME C; FLUORESCEIN; MARINOBUFAGENIN; PROTEIN BAK;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL PERMEABILITY; BLOOD VOLUME; CAPILLARY LEAK SYNDROME; CONTROLLED STUDY; DISEASE MODEL; EXTRAVASATION; EXTRAVASCULAR SPACE; FEMALE; HYPERTENSION; INTERSTITIAL FLUID; MALE; NONHUMAN; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; URINARY EXCRETION;

ANIMALS; BUFANOLIDES; CASPASE 3; CASPASE 8; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; STEROIDS; VASOCONSTRICTOR AGENTS;

EID: 59249099940     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000193220     Document Type: Article

References (29)

1. Scott DE: Anemia in pregnancy. Obstet Gynecol Annu 1972;1:219-244.
2. Chesley LC: Plasma and red cell volumes during pregnancy. Am J Obstet Gynecol 1972;112:440-450.
3. Hays PM, Cruikshank DP, Dunn LJ: Plasma volume determination in normal and pre-eclamptic pregnancies. Am J Obstet Gynecol 1985;151:958-966.
4. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK: Pre-eclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989;161:1200-1204.
5. Roberts JM: Endothelial dysfunction in pre-eclampsia. Semin Reprod Endocrinol 1998;16 : 5-15.
6. Ianosi-Irimie M, Vu HV, Whitbred JM, Pri-djian CA, Nadig JD, Williams MY, Wrenn DC, Pridjian G, Puschett JB: A rat model of preeclampsia. Clin Exp Hy pertens 2005;27:605-617.
7. Vu HV, Ianosi-Irimie MR, Pridjian CA, Whitbred JM, Durst JM, Bagrov AY, Fedorova OV, Pridjian G, Puschett JB: Involvement of marinobufagenin in a rat model of human preeclampsia. Am J Nephrol 2005;25:520-528.
8. Lopatin DA, Ailamazian EK, Dmitrieva RI, Shpen VM, Fedorova OV, Doris PA, Bagrov AY: Circulating bufadienolide and cardenolide sodium pump inhibitors in preeclampsia. J Hypertens 1999;17:1179 -1187.
9. Gonick HC, Ding Y, Vaziri ND, Bagrov AY, Fedorova OV: Simultaneous measurement of marinobufagenin, ouabain, and hypertension-associated protein in various disease states. Clin Exp Hy per tens 1998;20:617-627.
10. LaMarca HL, Morris CA, Pettit GR, Nagowa T, Puschett JB: Marinobufagenin impairs first trimester cytotrophoblast differentiation. Placenta 2006;27: 984-988.
11. Uddin MN, Horvat D, Glaser SS, Danchuk S, Mitchell BM, Sullivan DE, Morris CA, Pus-chett JB: Marinobufagenin inhibits proliferation and migration of cytotrophoblast and CHO cells. Placenta 2008;29:266-273.
12. Uddin MN, Horvat D, Glaser SS, Mitchell BM, Puschett JB: Examination of the cellular mechanisms by which marinobufagenin inhibits cytotrophoblast function. J Biol Chem 2008;283:17946 -17953.
13. Uddin MN, Hunter FA, Glaser SS, Horvat D, Childs EW, Puschett JB: Marinobufagenin impairs proliferation and triggered en-hanced vascular permeability in rat lung microvascular endothelial cells. J Invest Med 2008;56:481.
14. Bekker AY, Ritter AB, Duran WN: Analysis of microvascular permeability to macromol-ecules by video image digital processing. Mi-crovasc Res 1989;38:200-216.
15. Fedorova OV, Doris PA, Bagrov AY: Endogenous marinobufagenin-like factor in acute plasma volume expansion. Clin Exp Hypertens 1998;20:581-591.
16. Bagrov AY, Fedorova OV, Dmitrieva RI, French AW, Anderson DE: Plasma marinobufagenin-like and ouabain-like immunore-activity during saline volume expansion in anesthetized dogs. Cardiovasc Res 1996;31:296-305.
17. Wang Y, Gu Y, Granger DN, Roberts JM, Alexander JS: Endothelial junctional protein redistribution and increased monolayer permeability in human umbilical vein endothelial cells isolated during preeclampsia. Am J Obstet Gynecol 2002;186:214-220.
18. Childs EW, Tharakan B, Hunter FA, Tinsley JH, Cao X: Apoptotic signaling induces hy-perpermeability following hemorrhagic shock. Am J Physiol 2007;292:H3179-H3189.
19. Thornberry NA, Lazebnik Y: Caspases: enemies within. Science 1998;281:1312-1316.
20. Davidson MT, Deitch EA, Lu Q, Hasko G, Abungu B, Nemeth ZH, Zaets SB, Gaspers LD, Thomas AP, Xu DZ: Trauma-hemorrhagic shock mesenteric lymph induced endothelial apoptosis that involves both caspase-dependent and caspase-independent mechanisms. Ann Surg 2004;240:123-131.
21. Mauriz JL, Gonzalez P, Jorquera F, Olcoz JL, Gonzalez-Gallego J: Caspase inhibition does not protect against liver damage in hemor-rhagic shock. Shock 2003;19:33-37.
22. Murao Y, Hata M, Ohinishi K, Okuchi K, Na-kajima Y, Hiasa Y, Junger WG, Hoyt DB, Ohinishi T: Hypertonic saline resuscitation reduces apoptosis and tissue damage of the small intestine in a mouse model of hemorrhagic shock. Shock 2003;20:23-28.
23. Watts JA, Grattan RM, Whitlow BS, Kline JA: Activation of poly (ADP-ribose) polymerase in severe hemorrhagic shock and resuscitation. Am J Physiol 2001;281:G498-G506.
24. Tinsley JH, Breslin JW, Teasdale NR, Yuan SY: PKC-dependent, burn-induced adherens junction reorganization and barrier dysfunction in pulmonary microvascular endothelial cells. Am J Physiol 2005;289:L217-L223.
25. Tinsley JH, Ustinova EE, Xu W, Yuan SY Src-dependent, neutrophil-mediated vascular hyperpermeability and β-catenin modification. Am J Physiol 2002;283:C1745-C1751.
26. Tinsley JH, Wu MH, Ma W, Taulman AC, Yuan, SY: Activated neutrophils induce hyperpermeability and phosphorylation of adherens junction proteins in coronary venular endothelial cells. J Biol Chem 1999;274:24930-24934.
27. Yuan SY, Wu MH, Ustinova EE, Guo M, Tinsley JH, De Lanerolle P, Xu W: Myosin light chain phosphorylation in neutrophil-stimu-lated coronary microvascular leakage. Circ Res 2002;90:1214-1221.
28. Pridjian G, Puschett JB: Preeclampsia. Part 1: Clinical and pathophysiological considerations. Obstet Gynecol Surv 2002;57:598-618.
29. Pridjian G, Puschett JB: Preeclampsia. Part 2: Experimental and genetic considerations. Obstet Gynecol Surv 2002;57:619-640.